The right tests for detection and diagnosis
A comprehensive menu for diagnosing vector-borne diseases
Mayo Clinic’s internationally renowned clinical microbiology laboratories span all areas of conventional, molecular, and serological medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the pathogens associated with infectious diseases.
Mayo Clinic Laboratories offers a full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases (VBD). In addition to our comprehensive testing menu, we developed multiple VBD testing algorithms to help guide and optimize diagnostic testing.
Diagnostic testing for:
- Lyme disease
- Rocky Mountain spotted fever (RMSF)
- Borrelia miyamotoi disease
- West Nile virus
- Eastern equine virus
- Western equine virus
- California (La Crosse) virus
- St. Louis encephalitis virus
- Chikungunya virus
- Zika virus
- Dengue virus
Other vector-borne diseases
- Visceral leishmaniasis
- Parasite identification (arthropods)
- Chagas disease
Our vector-borne disease directors
Bobbi Pritt, M.D.
Dr. Bobbi Pritt is certified by the American Board of Pathology in clinical and anatomic pathology and microbiology. Her research interests include the evaluation and development of novel laboratory methods to aid in the diagnosis of parasitic and vector-borne diseases. Dr. Pritt works collaboratively with academic and public health partners to provide laboratory diagnostics and education in these areas to a global population. Some of her recent work resulted in the implementation of rapid and highly sensitive molecular tests for malaria, microsporidiosis, Lyme disease, and Borrelia miyamotoi infection. Dr. Pritt also played a key role in discovering and describing two new tick-borne pathogens: Ehrlichia muris eauclairensis and Borrelia mayonii. The latter bacterium causes Lyme disease in the upper Midwestern United States.
Dr. Elitza Theel is certified by the American Board of Medical Microbiology. Her research interests include development and evaluation of novel methods for antibody and antigen detection as diagnostics, specifically for vector-borne and fungal diseases. Dr. Theel also spearheads an international laboratory outreach initiative in Belize. This initiative is focused on increasing the in-country diagnostic testing capacity for vector-borne diseases and enhancing the current quality assurance/quality control practices in clinical laboratories throughout the country.
Elitza Theel, Ph.D.
Learn more about how to order these tests at your institution.